# K031100: Synthes Ventrofix Mis System

- Pathway: 510(k) (Traditional)
- Applicant: Synthes (Usa)
- Decided: Mar 4, 2004 after 332 days
- Product code: KWQ (Appliance, Fixation, Spinal Intervertebral Body)
- Device class: 2
- Regulation: 21 CFR 888.3060
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
508 later devices descend from it; 2 cite it directly.
1 of 509 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K081568: Antegra-T (2008), 472 descendants of its own
- K121815: Nuvasive Sage Lateral Plate System (2012), 469 descendants of its own
- K131723: Coroent Single Tab System (2013), 466 descendants of its own
- K140479: Coroent XL-F System (2014), 465 descendants of its own
- K160051: NuVasive® Interfixated Interbody System (2016), 396 descendants of its own

## Indications for use
The Synthes VentroFix MIS System is indicated for use, via the lateral or anterolateral surgical approach, in the treatment of thoracic and thoracolumbar (T1-L5) spine instability as a result of degenerative disc disease (defined as pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), spondylolisthesis, spondylolysis, fracture (including dislocation and subluxation), spinal stenosis, deformities (i.e., scoliosis, kyphosis, lordosis whether neuromuscular or related to deficient posterior elements), tumors (neoplastic disease), pseudoarthrosis, or a failed previous fusion.

Source page: https://510kreport.com/device/K031100
Methodology: https://510kreport.com/methodology